Home About us Contact
|
Home About us Contact | ||
|
|
||
Novel Delivery System (novel + delivery_system)
Selected AbstractsReduction-Sensitive Self-Aggregates as a Novel Delivery SystemMACROMOLECULAR CHEMISTRY AND PHYSICS, Issue 8 2010Ju Eun Kim Abstract Methoxy PEG amine with molecular weight of 5k and , -caprolactone with molecular weight of 1,960 were conjugated to a peptide comprising three cysteine residues. The shift of peak molecular weight and narrow molecular weight distribution in GPC trace without any noticeable shoulder as well as 1H NMR analysis confirmed the successful synthesis of the copolymer. A modified O/W dialysis system was employed to prepare self-aggregates having the size around 210,nm. During the dialysis, stabilized aggregates were obtained by intermolecular disulfide bonds via oxidation. Critical aggregate concentration (CAC) of the copolymer was determined as 0.07,mg,·,mL,1 and disulfide-stabilized self-aggregates remained stable regardless of the concentration without displaying CAC. Doxorubicin-loading amount and efficiency was 8.7 and 26.0%, respectively. Release profile of doxorubicin below CAC at 37,°C showed a sustained release and the addition of D,L -dithiothreitol (DTT) after 24,h triggered a burst release of doxorubicin. Intermolecular disulfide bonds via oxidation stabilized the polymeric aggregates even in the diluted condition similar to that in the bloodstream and addition of DTT destabilized the aggregates to burst encapsulated doxorubicin in the reductive condition. [source] Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disordersJOURNAL OF NEUROCHEMISTRY, Issue 2 2010William M. Armstead J. Neurochem. (2010) 113, 303,312. Abstract Stroke is a leading cause of morbidity and mortality. While tissue-type plasminogen activator (tPA) remains the only FDA-approved treatment for ischemic stroke, clinical use of tPA has been constrained to roughly 3% of eligible patients because of the danger of intracranial hemorrhage and a narrow 3 h time window for safe administration. Basic science studies indicate that tPA enhances excitotoxic neuronal cell death. In this review, the beneficial and deleterious effects of tPA in ischemic brain are discussed along with emphasis on development of new approaches toward treatment of patients with acute ischemic stroke. In particular, roles of tPA-induced signaling and a novel delivery system for tPA administration based on tPA coupling to carrier red blood cells will be considered as therapeutic modalities for increasing tPA benefit/risk ratio. The concept of the neurovascular unit will be discussed in the context of dynamic relationships between tPA-induced changes in cerebral hemodynamics and histopathologic outcome of CNS ischemia. Additionally, the role of age will be considered since thrombolytic therapy is being increasingly used in the pediatric population, but there are few basic science studies of CNS injury in pediatric animals. [source] Temperature-Triggered Nanosphere Formation Through Self-Assembly of Amphiphilic PolyphosphazeneMACROMOLECULAR CHEMISTRY AND PHYSICS, Issue 14 2006Jian Xiang Zhang Abstract Summary: An amphiphilic graft polyphosphazene with a molar ratio of poly(N -isopropylacrylamide) (PNIPAm) to ethyl glycinate (GlyEt) of 0.54:1 was synthesized. This copolymer in aqueous solution exhibited two temperature induced phase transitions at 17.2 and 33.7,°C, which correspond to the transformation of primary aggregate morphology (at Tph1) and the collapse of PNIPAm chains (at Tph2) respectively. Network micelles were assembled in water at lower temperature (far below Tph1), and then narrowly dispersed nanoparticles were formed above Tph1, while inter-nanoparticle aggregation occurred due to the collapse of PNIPAm chains surrounding the GlyEt core when the temperature was above Tph2. Through solubilization of the hydrophobic drug ibuprofen into polymeric aggregates at lower temperature, drug loaded nanospheres were prepared successfully. In vitro release revealed that sustained drug release was achieved with this novel delivery system. These results suggest that this novel copolymer could be used as a potential drug carrier, especially for the delivery of hydrophobic biocompounds through parenteral administration. Schematic illustration of the temperature-triggered self-assembly process of PNIPAm/GlyEt-PPP in aqueous solution. [source] Adhesive powder uptake and transfer by Mediterranean fruit flies, Ceratitis capitata (Dipt., Tephritidae)JOURNAL OF APPLIED ENTOMOLOGY, Issue 5 2006L. Barton Abstract:, EntostatTM is an electrostatically charged wax powder that is used as a carrier particle in novel delivery systems for contaminating target insect pests with insecticides, biologicals or pheromones. Here, the adhesion of two forms of Entostat to the Mediterranean fruit fly (medfly) Ceratitis capitata (Wiedemann) was examined, and the adhesion of Entostat to live and dead medflies was compared. From controlled contaminations of medflies, it was shown that live medflies acquired larger quantities of Entostat than dead medflies, which could be due to the electrostatic charge shown to be carried by live insects. Air-milled Entostat (7.59 ,m mean diameter) adhered in larger quantities to medflies than pestle and mortar-ground Entostat (9.17 ,m mean diameter). Exposing medflies to different quantities of Entostat affected the initially adhering quantity but did not alter the proportion of powder retained over time. Medfly males contaminated with air-milled Entostat were shown to transfer small quantities to females during mating. This documentation of secondary powder transfer underscores the potential for using slow-acting killing agents on the basis of this delivery system. [source] Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?BJU INTERNATIONAL, Issue 2007Scott A. MacDiarmid SUMMARY Urinary incontinence affects an estimated 20,33% of adults the USA and 55% of the country's elderly [1], having a more substantial impact on the physical and mental dimension of quality of life than other common chronic diseases. Muscarinic receptor antagonists, including oxybutynin, tolterodine, trospium chloride, darifenacin, and solifenacin, are front-line therapies for overactive bladder (OAB), with an efficacy of 65,75% in reducing major symptoms. Strategies to increase the therapeutic index have included behavioural therapy, flexible dosing, and dose escalation, as well as newer formulations that reduce anticholinergic side-effects. Among approved OAB agents, the oxybutynin transdermal-delivery system has been associated with a lower incidence of dry mouth than immediate- and extended-release formulations of traditional agents. With a low propensity for drug interactions and dry mouth, it is a likely candidate for older patients taking multiple medications. The transdermal patch bypasses systemic and first-pass metabolism, avoiding higher plasma concentrations of the active metabolite (N -desethyloxybutynin) thought to be associated with dry mouth symptoms. Anticholinergics have a significant role to play in the management of OAB; newer drugs targeted toward muscarinic receptors, and novel delivery systems, continue to increase the therapeutic index for this condition. [source] | ||||||||||